AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.580
+0.100 (2.23%)
At close: May 22, 2026, 4:00 PM EDT
4.781
+0.201 (4.40%)
After-hours: May 22, 2026, 7:56 PM EDT

AVITA Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '21
Net Income
-45.34-48.59-61.85-35.38-26.67-26.58
Other Adjustments
0.32-----
Operating Cash Flow
-45.02-48.59-61.85-35.38-26.67-26.58
Long-Term Debt Issued
49.08-----
Long-Term Debt Repaid
-42.98-----
Net Long-Term Debt Issued (Repaid)
6.1-----
Financing Cash Flow
6.1-----
Net Cash Flow
-38.92-48.59-61.85-35.38-26.67-26.58
Free Cash Flow
-45.02-48.59-61.85-35.38-26.67-26.58
FCF Margin
-62.23%-67.85%-96.26%-70.56%-77.47%-90.94%
Free Cash Flow Per Share
-31.13-34.88-47.79-27.93-21.33-23.45
Levered Free Cash Flow
-4.51-48.59-61.85-35.38-26.67-26.58
Unlevered Free Cash Flow
-39.49-42.54-56.64-42.73-27.54-26.58
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q